NOVARTIS AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 89.5 CHF | -0.56% |
|
+4.64% | +5.46% |
| 04-26 | NOVARTIS AG : Receives a Buy rating from Jefferies | ZD |
| 04-24 | BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NOVARTIS AG | Other Pharmaceuticals | -0.56% | +4.64% | +5.46% | -2.36% | +8.35% | 200B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- NOVN Stock
- Charts Novartis AG
- Comparison Chart
